HIFA-B 📈 Hifab Group AB Series B - Overview
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0000483943
HIFA-B: Project Management, Real Estate Services, Civil Engineering Advice
Hifab Group AB (publ) provides project management and consulting services in Sweden, rest of Europe, Asia, and Africa. It offers advisory services for the in real estate and civil engineering industry. The company was founded in 1947 and is headquartered in Stockholm, Sweden. Web URL: https://www.hifab.se
Additional Sources for HIFA-B Stock
HIFA-B Stock Overview
Market Cap in USD | 18m |
Sector | Industrials |
Industry | Engineering & Construction |
GiC Sub-Industry | Research & Consulting Services |
IPO / Inception |
HIFA-B Stock Ratings
Growth 5y | 32.3% |
Fundamental | 45.6% |
Dividend | 8.28% |
Rel. Strength Industry | 40.7 |
Analysts | - |
Fair Price Momentum | 2.98 SEK |
Fair Price DCF | 6.15 SEK |
HIFA-B Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 27.6% |
HIFA-B Growth Ratios
Growth Correlation 3m | -56.9% |
Growth Correlation 12m | 79.5% |
Growth Correlation 5y | 30.6% |
CAGR 5y | 5.50% |
CAGR/Mean DD 5y | 0.30 |
Sharpe Ratio 12m | 0.52 |
Alpha | 7.57 |
Beta | 0.37 |
Volatility | 62.51% |
Current Volume | 5.4k |
Average Volume 20d | 20.7k |
What is the price of HIFA-B stocks?
As of December 21, 2024, the stock is trading at SEK 3.12 with a total of 5,350 shares traded.
Over the past week, the price has changed by -4.35%, over one month by -2.53%, over three months by -1.28% and over the past year by +25.20%.
As of December 21, 2024, the stock is trading at SEK 3.12 with a total of 5,350 shares traded.
Over the past week, the price has changed by -4.35%, over one month by -2.53%, over three months by -1.28% and over the past year by +25.20%.
Is Hifab Group AB Series B a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Hifab Group AB Series B (ST:HIFA-B) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 45.62 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIFA-B as of December 2024 is 2.98. This means that HIFA-B is currently overvalued and has a potential downside of -4.49%.
Partly, yes. Based on ValueRay Fundamental Analyses, Hifab Group AB Series B (ST:HIFA-B) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 45.62 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIFA-B as of December 2024 is 2.98. This means that HIFA-B is currently overvalued and has a potential downside of -4.49%.
Is HIFA-B a buy, sell or hold?
Hifab Group AB Series B has no consensus analysts rating.
Hifab Group AB Series B has no consensus analysts rating.
What are the forecast for HIFA-B stock price target?
According to ValueRays Forecast Model, HIFA-B Hifab Group AB Series B will be worth about 3.2 in December 2025. The stock is currently trading at 3.12. This means that the stock has a potential upside of +3.85%.
According to ValueRays Forecast Model, HIFA-B Hifab Group AB Series B will be worth about 3.2 in December 2025. The stock is currently trading at 3.12. This means that the stock has a potential upside of +3.85%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 3.2 | 3.8% |